PCN96 A TRIAL-BASED ASSESSMENT OF THE COST-UTILITY OF BEVACIZUMAB AND CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
May 1, 2010, 00:00
10.1016/S1098-3015(10)72185-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)72185-9/fulltext
Title :
PCN96 A TRIAL-BASED ASSESSMENT OF THE COST-UTILITY OF BEVACIZUMAB AND CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72185-9&doi=10.1016/S1098-3015(10)72185-9
First page :
Section Title :
Open access? :
No
Section Order :
774